Thyrocare Technologies Sets Record Date for Bonus Shares Issuance on November 28, 2025

Thyrocare Technologies, an Indian healthcare company, has set a record date for issuing bonus shares. The decision was made during a Board meeting on November 16, 2025. Shareholders will receive two bonus shares for each existing share they own. This move aims to reward shareholders and enhance liquidity. The bonus shares will have the same rights as the existing ones.

The company had previously informed the exchange about the bonus issue on October 14, 2025. On November 16, 2025, shareholders officially approved the issuance of these bonus shares. Each bonus share will have a face value of Rs 10, similar to the current shares. This initiative is seen as a significant step in benefiting shareholders.According to Regulation 42 of the SEBI Listing Regulations, Thyrocare Technologies has set Friday, November 28, 2025, as the record date. This date determines which shareholders are eligible for the bonus shares. The allotment is scheduled for Monday, December 1, 2025. Trading of these shares will commence on Tuesday, December 2, 2025.The company plans to issue a total of 10,61,07,794 bonus equity shares. Each share will have a face value of Rs 10. However, this number might change depending on stock option exercises under the Thyrocare Employee Stock Option Scheme by the record date.As of September 30, 2025, Thyrocare's issued capital stands at Rs 53,05,38,970. This comprises 5,30,53,897 equity shares valued at Rs 10 each. Before the bonus issue, the authorized capital was Rs 1 billion divided into ten crore equity shares of Rs 10 each.The funds for these bonus shares will be drawn from various reserves and earnings. These include the Securities Premium Account, Capital Redemption Reserve, Free Reserves, and Retained Earnings. The company plans to distribute these shares within two months after Board approval and before December 13, 2025.

Thyrocare Technologies Target Price

A R Ramachandran from Tips2trades commented on Thyrocare's stock performance. "Thyrocare Technologies stock price is bearish & also overbought on the Daily charts with strong resistance at 1609. Investors should be booking profits as a Daily close below support of 1560 could lead to a target of 1399 in the near term," he noted.The company's unaudited financials as of September 30, 2025, show that funds from free reserves will be used for this purpose. These reserves include Capital Redemption Reserve (Rs 0.96 crore), Securities Premium (Rs 78.09 crore), General Reserve (Rs 205.42 crore), and Retained Earnings (Rs 76.29 crore).This information is provided solely for educational purposes and should not be considered investment advice. Readers are encouraged to verify details with licensed financial advisors before making any investment decisions.